ASO Author Reflections: Response to Chemotherapy Differs between Precursor Epithelial Subtypes of Pancreatic Adenocarcinoma Arising from Intraductal Papillary Mucinous Neoplasms and may Warrant Tailored Treatment to Improve Outcomes.

作者信息

Lucocq James, Soreide Kjetil, Pandanaboyana Sanjay

机构信息

Department of General Surgery, Royal Infirmary of Edinburgh, Edinburgh, Scotland.

Department of Surgery, Stavanger University Hospital, Stavanger, Norway.

出版信息

Ann Surg Oncol. 2024 Oct;31(10):7070-7071. doi: 10.1245/s10434-024-15784-x. Epub 2024 Jul 6.

DOI:10.1245/s10434-024-15784-x

PMID:38971954

Abstract

摘要

相似文献

[1]

ASO Author Reflections: Response to Chemotherapy Differs between Precursor Epithelial Subtypes of Pancreatic Adenocarcinoma Arising from Intraductal Papillary Mucinous Neoplasms and may Warrant Tailored Treatment to Improve Outcomes.

Ann Surg Oncol. 2024-10

[2]

Precursor Epithelial Subtypes of Adenocarcinoma Arising from Intraductal Papillary Mucinous Neoplasms (A-IPMN): Clinicopathological Features, Recurrence and Response to Adjuvant Chemotherapy.

Ann Surg Oncol. 2024-10

[3]

Adjuvant chemotherapy for adenocarcinoma arising from intraductal papillary mucinous neoplasia: multicentre ADENO-IPMN study.

Br J Surg. 2024-4-3

[4]

Predictors of long-term survival after resection of adenocarcinoma arising from intraductal papillary mucinous neoplasm and derivation of a prognostic model: An international multicenter study (ADENO-IPMN study).

Surgery. 2024-9

[5]

[Report of two clinical-pathological cases of pancreatic intraductal papillary neoplasms with distinct phenotype and outcome].

Gastroenterol Hepatol. 2015-2

[6]

Pancreatic cancer arising in intraductal papillary mucinous neoplasms (IPMN): emerging data warrants further research.

Br J Surg. 2024-10-1

[7]

ASO Author Reflections: Systemic Immune-Inflammation Index (SII) as a Biomarker of Response to Neoadjuvant Therapy in Patients with Pancreatic Adenocarcinoma.

Ann Surg Oncol. 2020-3

[8]

Risk of Recurrence After Surgical Resection for Adenocarcinoma Arising From Intraductal Papillary Mucinous Neoplasia (IPMN) With Patterns of Distribution and Treatment: An International, Multicenter, Observational Study (ADENO-IPMN Study).

Ann Surg. 2024-7-1

[9]

Pancreatic intraductal papillary-mucinous neoplasms: a new and evolving entity.

Virchows Arch. 2007-11

[10]

Outcomes of Neoadjuvant Chemotherapy for Invasive Intraductal Papillary Mucinous Neoplasm Compared with de Novo Pancreatic Adenocarcinoma.

Ann Surg Oncol. 2024-4

本文引用的文献

[1]

Adjuvant chemotherapy for adenocarcinoma arising from intraductal papillary mucinous neoplasia: multicentre ADENO-IPMN study.

Br J Surg. 2024-4-3

[2]

Adjuvant Chemotherapy in the Treatment of Intraductal Papillary Mucinous Neoplasms of the Pancreas: Systematic Review and Meta-Analysis.

World J Surg. 2022-1

[3]

Fate of Patients With Intraductal Papillary Mucinous Neoplasms of Pancreas After Resection According to the Pathology and Margin Status: Continuously Increasing Risk of Recurrence Even After Curative Resection Suggesting Necessity of Lifetime Surveillance.

Ann Surg. 2022-10-1

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

ASO Author Reflections: Response to Chemotherapy Differs between Precursor Epithelial Subtypes of Pancreatic Adenocarcinoma Arising from Intraductal Papillary Mucinous Neoplasms and may Warrant Tailored Treatment to Improve Outcomes.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

本文引用的文献